ESGO eAcademy, The Official eLearning Portal of the European Society of Gynaecological Oncology

Create Account Sign In
New Frontiers in Treating Metastatic Cervical Cancer From Revolutionary Molecules to Clinical Therapies
Chair(s):
Ignace Vergote
Ignace Vergote
Affiliations:
Speaker(s):
Christian Marth
,
Christian Marth
Affiliations:
Isabelle Ray-Coquard
,
Isabelle Ray-Coquard
Affiliations:
Mansoor Raza Mirza
,
Mansoor Raza Mirza
Affiliations:
Domenica Lorusso
Domenica Lorusso
Affiliations:
ESGO eAcademy. Presenters F. 10/23/21; 346489
Ignace Vergote
Christian Marth
Isabelle Ray-Coquard
Mansoor Raza Mirza
Domenica Lorusso
Login now to access Regular content available to all registered users.
Click here to create a free account.

Access to Premium content is currently a membership benefit.

Click here to join ESGO or renew your membership.

You may also access ESGO content "anytime, anywhere" with the FREE ESGO eAcademy App for iOS and Android.
About this activity
Discussion Forum (0)
Chair: Ignace Vergote (Belgium)

15:00-15:05     Introduction by Ignace Vergote (Belgium)
15:05-15:20     Perspectives on current treatment landscape for r/m CC by Christian Marth (Austria), Ignace Vergote (Belgium)
15:20-15:35     Experts discuss future treatment modalities for r/m CC byIsabelle Ray-Coquard (France), Mansoor Raza Mirza (Denmark)
15:35-15:50     Can ADCs change r/m CC treatment landscape? by Domenica Lorusso (Italy), Ignace Vergote (Belgium)
15:50-16:00     Live Q&A

Technical Settings:
This live session is available on PC, Tablet and Smartphones. For the best viewing experience, a high-speed internet connection is required. If you have a problem accessing the live webinar, please contact the technical support team at support@multilearning.com. 
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies